Smolen J - Search Results

1

B-cell targeted therapeutics in clinical development.

Blüml S, McKeever K, Ettinger R, Smolen J, Herbst R. Blüml S, et al. Among authors: smolen j. Arthritis Res Ther. 2013;15 Suppl 1(Suppl 1):S4. doi: 10.1186/ar3906. Epub 2013 Apr 4. Arthritis Res Ther. 2013. PMID: 23566679 Free PMC article. Review.

2

Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.

Blüml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, Schett G, Scheinecker C, Kollias G, Selzer E, Bilban M, Smolen JS, Superti-Furga G, Redlich K. Blüml S, et al. Arthritis Rheum. 2010 Jun;62(6):1608-19. doi: 10.1002/art.27399. Arthritis Rheum. 2010. PMID: 20155834 Free article.

3

Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice.

Blüml S, Bonelli M, Niederreiter B, Puchner A, Mayr G, Hayer S, Koenders MI, van den Berg WB, Smolen J, Redlich K. Blüml S, et al. Among authors: smolen j. Arthritis Rheum. 2011 May;63(5):1281-8. doi: 10.1002/art.30281. Arthritis Rheum. 2011. PMID: 21321928 Free article.

4

Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.

Karonitsch T, von Dalwigk K, Steiner CW, Blüml S, Steiner G, Kiener HP, Smolen JS, Aringer M. Karonitsch T, et al. Arthritis Rheum. 2012 Feb;64(2):400-8. doi: 10.1002/art.33347. Arthritis Rheum. 2012. PMID: 21953607 Free article.

5

Targeting TNF receptors in rheumatoid arthritis.

Blüml S, Scheinecker C, Smolen JS, Redlich K. Blüml S, et al. Int Immunol. 2012 May;24(5):275-81. doi: 10.1093/intimm/dxs047. Epub 2012 Mar 28. Int Immunol. 2012. PMID: 22457216 Review.

6

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis.

Bonelli M, Ferner E, Göschl L, Blüml S, Hladik A, Karonitsch T, Kiener HP, Byrne R, Niederreiter B, Steiner CW, Rath E, Bergmann M, Smolen JS, Scheinecker C. Bonelli M, et al. Among authors: smolen js. Arthritis Rheum. 2013 Mar;65(3):599-607. doi: 10.1002/art.37787. Arthritis Rheum. 2013. PMID: 23203906 Free article.

7

Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis.

Binder NB, Puchner A, Niederreiter B, Hayer S, Leiss H, Blüml S, Kreindl R, Smolen JS, Redlich K. Binder NB, et al. Arthritis Rheum. 2013 Mar;65(3):608-17. doi: 10.1002/art.37797. Arthritis Rheum. 2013. PMID: 23280418 Free article.

8

Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.

Blüml S, Friedrich M, Lohmeyer T, Sahin E, Saferding V, Brunner J, Puchner A, Mandl P, Niederreiter B, Smolen JS, Schabbauer G, Redlich K. Blüml S, et al. Among authors: smolen js. Ann Rheum Dis. 2015 Jan;74(1):227-33. doi: 10.1136/annrheumdis-2013-203486. Epub 2013 Sep 27. Ann Rheum Dis. 2015. PMID: 24078675

9

CD4⁺CD25⁻Foxp3⁺ T cells: a marker for lupus nephritis?

Bonelli M, Göschl L, Blüml S, Karonitsch T, Steiner CW, Steiner G, Smolen JS, Scheinecker C. Bonelli M, et al. Arthritis Res Ther. 2014 Apr 28;16(2):R104. doi: 10.1186/ar4553. Arthritis Res Ther. 2014. PMID: 24774748 Free PMC article.

10

Mechanisms of tissue damage in arthritis.

Blüml S, Redlich K, Smolen JS. Blüml S, et al. Semin Immunopathol. 2014 Sep;36(5):531-40. doi: 10.1007/s00281-014-0442-8. Epub 2014 Sep 12. Semin Immunopathol. 2014. PMID: 25212687 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,147 results

Search Page